In addition, the selective targeting of PD-L1 only in tumor-draining lymph nodes demonstrated effective anti-tumor T-cell responses, and PD-1/PD-L1 interaction in tumor-draining lymph nodes, but not in the tumor, was correlated with prognosis in melanoma (69). This evidence concerns the gene CD274 and melanoma.